(PharmaNewsWire.Com, August 09, 2017 ) The Glucose Monitoring Device Market of the Middle East and Africa is likely to account for USD 231.53 million in 2021 at a CAGR of 6.08% from USD 172.3 million in 2016 to 2021.
Glucose level in blood can be detected by using these glucose monitoring devices and these are of several kinds which include glucose meter, testing strips and lancets. By using the single glucose meter and different strips we can self-test the sugar level.
The continuous glucose monitoring results help patients regulate their food intake, exercise, and medications. The device contains sensors for checking glucose level from the interstitial fluid. The sensor has a time span where it can be used at one place and then needs to be replaced. This device monitors the glucose levels over time, allowing the patients to identify low and high sugar levels which are more dangerous. Whereas for the self-monitoring devices people have to test and it monitors the level at that particular time and not before that.
It offers the services of monitoring glucose level in our blood as it tests quantitatively. These devices can be handled easily as are portable so convenient to carry. The devices allow the test to be performed by the patient as per their convenience at their home, which makes them popular.
The healthcare expenditure is increasing which is the direct cause for the increase in growth of the market of self-monitoring blood glucose devices. The increasing prevalence of diabetes cases is due to unhealthy lifestyle, poor diet, excess alcohol consumption, and lack of physical activity. However, this market faces certain loss due to some manufacturing defect or error in results.
This market can be broadly segmented into continuous wearable devices (Sensors, Transmitters and Activators) and self-monitoring devices (Blood Glucose Meters, Blood Glucose Strips, Lancets, and Haemoglobin A1C testing Kits). Based on Application they can be divided into hospitals, clinics and diagnostic centers, home setting and ambulatory settings. In addition to that, the Middle East and Africa Glucose monitoring device market can be subdivided geographically into GCC, Egypt, and South Africa.
The market includes the companies Roche Diagnostics, LifeScan, Bayer Health care, Abbott Diabetes care Inc, AgaMatrix Inc, Arkray Inc, Medtronic, DexCom Inc, Nova Biomedical Corporation and Teruma Europe NV.
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
